Achillion Pharmaceuticals, Inc. (ACHN) Tops Q2 EPS by 2c

August 7, 2014 4:27 PM EDT

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings